178 related articles for article (PubMed ID: 12445671)
1. Menin interacting proteins as clues toward the understanding of multiple endocrine neoplasia type 1.
Poisson A; Zablewska B; Gaudray P
Cancer Lett; 2003 Jan; 189(1):1-10. PubMed ID: 12445671
[TBL] [Abstract][Full Text] [Related]
2. Functional studies of the MEN1 gene.
Chandrasekharappa SC; Teh BT
J Intern Med; 2003 Jun; 253(6):606-15. PubMed ID: 12755956
[TBL] [Abstract][Full Text] [Related]
3. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.
Wautot V; Vercherat C; Lespinasse J; Chambe B; Lenoir GM; Zhang CX; Porchet N; Cordier M; Béroud C; Calender A
Hum Mutat; 2002 Jul; 20(1):35-47. PubMed ID: 12112656
[TBL] [Abstract][Full Text] [Related]
4. The gene for multiple endocrine neoplasia type 1: recent findings.
Marx SJ; Agarwal SK; Heppner C; Kim YS; Kester MB; Goldsmith PK; Skarulis MC; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree JS; Collins FS; Chandrasekharappa SC
Bone; 1999 Jul; 25(1):119-22. PubMed ID: 10423035
[TBL] [Abstract][Full Text] [Related]
5. Menin molecular interactions: insights into normal functions and tumorigenesis.
Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
[TBL] [Abstract][Full Text] [Related]
6. Menin is required for optimal processing of the microRNA let-7a.
Gurung B; Muhammad AB; Hua X
J Biol Chem; 2014 Apr; 289(14):9902-8. PubMed ID: 24563463
[TBL] [Abstract][Full Text] [Related]
7. Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy.
Marini F; Brandi ML
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298972
[TBL] [Abstract][Full Text] [Related]
8. Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).
Canaff L; Vanbellinghen JF; Kaji H; Goltzman D; Hendy GN
J Biol Chem; 2012 Mar; 287(11):8584-97. PubMed ID: 22275377
[TBL] [Abstract][Full Text] [Related]
9. Menin associates with FANCD2, a protein involved in repair of DNA damage.
Jin S; Mao H; Schnepp RW; Sykes SM; Silva AC; D'Andrea AD; Hua X
Cancer Res; 2003 Jul; 63(14):4204-10. PubMed ID: 12874027
[TBL] [Abstract][Full Text] [Related]
10. Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients.
Luzi E; Marini F; Tognarini I; Carbonell Sala S; Galli G; Falchetti A; Brandi ML
Cancer Gene Ther; 2010 Nov; 17(11):814-25. PubMed ID: 20706287
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics analyses of MEN1 missense mutations identify disruption of menin-MLL and menin-JunD interactions as critical requirements for molecular pathogenicity.
Dreijerink KMA; Ozyerli-Goknar E; Koidl S; van der Lelij EJ; van den Heuvel P; Kooijman JJ; Biniossek ML; Rodenburg KW; Nizamuddin S; Timmers HTM
Epigenetics Chromatin; 2022 Aug; 15(1):29. PubMed ID: 35941657
[TBL] [Abstract][Full Text] [Related]
12. Menin: a scaffold protein that controls gene expression and cell signaling.
Matkar S; Thiel A; Hua X
Trends Biochem Sci; 2013 Aug; 38(8):394-402. PubMed ID: 23850066
[TBL] [Abstract][Full Text] [Related]
13. Global gene expression in neuroendocrine tumors from patients with the MEN1 syndrome.
Dilley WG; Kalyanaraman S; Verma S; Cobb JP; Laramie JM; Lairmore TC
Mol Cancer; 2005 Feb; 4(1):9. PubMed ID: 15691381
[TBL] [Abstract][Full Text] [Related]
14. Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1.
Guo SS; Sawicki MP
Mol Endocrinol; 2001 Oct; 15(10):1653-64. PubMed ID: 11579199
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
[TBL] [Abstract][Full Text] [Related]
16. Review: multiple endocrine neoplasia type 1, sporadic neuroendocrine tumors, and MENIN.
Komminoth P
Diagn Mol Pathol; 1999 Sep; 8(3):107-12. PubMed ID: 10565680
[TBL] [Abstract][Full Text] [Related]
17. The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells.
Sayo Y; Murao K; Imachi H; Cao WM; Sato M; Dobashi H; Wong NC; Ishida T
Endocrinology; 2002 Jun; 143(6):2437-40. PubMed ID: 12021209
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide characterization of menin-dependent H3K4me3 reveals a specific role for menin in the regulation of genes implicated in MEN1-like tumors.
Agarwal SK; Jothi R
PLoS One; 2012; 7(5):e37952. PubMed ID: 22666422
[TBL] [Abstract][Full Text] [Related]
19. Foxa2, a novel protein partner of the tumour suppressor menin, is deregulated in mouse and human MEN1 glucagonomas.
Bonnavion R; Teinturier R; Gherardi S; Leteurtre E; Yu R; Cordier-Bussat M; Du R; Pattou F; Vantyghem MC; Bertolino P; Lu J; Zhang CX
J Pathol; 2017 May; 242(1):90-101. PubMed ID: 28188614
[TBL] [Abstract][Full Text] [Related]
20. MEN1 tumor-suppressor protein localizes to telomeres during meiosis.
Suphapeetiporn K; Greally JM; Walpita D; Ashley T; Bale AE
Genes Chromosomes Cancer; 2002 Sep; 35(1):81-5. PubMed ID: 12203793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
